Analyst Coverage
| Firm | Analyst | Contact Information |
|---|---|---|
|
Bank of America/Merrill Lynch
|
Sachin Jain | |
|
Barclays
|
Emily Field | |
|
Bernstein
|
Wimal Kapadia | |
|
BMO
|
Etzer Darout, PhD | |
|
Bryan, Garnier & Co
|
Dylan van Haaften | |
|
Carnegie Bank
|
Jesper Ilsøe | |
|
Citi
|
Peter Verdult | |
|
Cowen
|
Yaron Werber, M.D. | |
|
Credit Suisse
|
Elizabeth Walton | |
|
Danske Markets Equities
|
Thomas Bowers | |
|
Deutsche Bank AG
|
Emmanuel Papadakis, PhD CFA | |
|
DNB
|
Rune Majlund Dahl | |
|
Goldman Sachs International
|
Keyur Parekh | |
|
Guggenheim Securities, LLC
|
Michael Schmidt, Ph.D. | |
|
Handelsbanken
|
Suzanna Queckbörner, PhD | |
|
H.C. Wainwright & Co.
|
Raghuram Selvaraju, Ph.D. | |
|
Jefferies International Ltd.
|
Peter Welford | |
|
J.P. Morgan
|
James Gordon | |
|
Jyske Bank
|
Henrik Hallengreen Laustsen | |
|
Kempen & Co
|
Suzanne van Voorthuizen | |
|
Morgan Stanley & Co. LLC
|
Matthew Harrison | |
|
Nordea
|
Michael Novod | |
|
Nykredit
|
Michael Drøscher Jørgensen | |
|
RBC Capital Markets, LLC
|
Zoe Karamanoli | |
|
Societe Generale
|
Justin Smith | |
|
SVB Securities
|
Jonathan Chang | |
|
Sydbank
|
Søren Løntoft Hansen | |
|
Truist Securities
|
Asthika Goonewardene |
Genmab A/S is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Genmab A/S's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Genmab A/S or its management. Genmab A/S does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.